V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010302 | 330004716 | 1.62 | 59 | Not known (9) | 2018-10-12 | 2018-11-28 | CARBOPLATIN + RT | N | N | 330013163 | CARBOPLATIN + RT |
| 330010303 | 330004718 | 1.57 | 71 | Palliative (P) | 2016-10-11 | 2016-11-05 | CARBOPLATIN + RT | N | Y | 330013170 | CARBOPLATIN + RT |
| 330010304 | 330004720 | 0 | 89.6 | Not known (9) | 2017-11-09 | 2018-05-11 | Cetuximab + Radiotherapy Load | N | N | 330013173 | CETUXIMAB + RT |
| 330010305 | 330004722 | 1.77 | 79 | Curative (C) | 2014-10-31 | 2014-11-04 | ALL UKALL2011 Maintenance A3 | 02 | N | 330013174 | UKALL2011 |
| 330010306 | 330008572 | 1.66 | null | Curative (C) | 2015-12-03 | 2015-12-10 | ALL UKALL2011 Maintenance A1 | N | N | 330013182 | UKALL2011 |
| 330010307 | 330004724 | 0 | 78 | Palliative (P) | 2015-03-25 | 2015-03-31 | VAI (Ifos 3g/m2) | N | N | 330013187 | VAI |
| 330010308 | 330013054 | 1.72 | 61.9 | Curative (C) | 2014-03-31 | 2014-04-16 | ALL UKALL2011 (ProtM-A) C PegAsp | N | N | 330013194 | UKALL2011 |
| 330010309 | 330004728 | 1.7 | 80.1 | Palliative (P) | null | 2017-08-31 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330013222 | CARBOPLATIN + PACLITAXEL |
| 330010310 | 330004730 | 1.77 | null | Palliative (P) | 2014-01-26 | 2014-02-23 | Carboplatin + Etoposide IV 3 day | N | null | 330013223 | CARBOPLATIN + ETOPOSIDE |
| 330010311 | 330008576 | 1.63 | 43.8 | Adjuvant (A) | 2015-04-19 | 2015-05-28 | VAI (Ifos 3g/m2) | 2 | Y | 330013229 | VAI |
| 330010312 | 330004733 | null | 86 | Palliative (P) | 2015-09-12 | 2015-09-12 | Carboplatin + Etoposide iv&po | 02 | null | 330013242 | CARBOPLATIN + ETOPOSIDE |
| 330010313 | 330004735 | 1.7 | 88 | null | 2017-12-03 | 2017-12-17 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 330013247 | BENDAMUSTINE + RITUXIMAB |
| 330010314 | 330004741 | 1.78 | 69.1 | Palliative (P) | 2013-04-16 | 2013-05-14 | BENDAMUSTINE + RITUXIMAB | N | N | 330013250 | BENDAMUSTINE + RITUXIMAB |
| 330010315 | 330008581 | 1.78 | 68.5 | Palliative (P) | 2017-02-22 | 2017-08-25 | EURAMOS TRIAL | N | N | 330013250 | EURAMOS TRIAL |
| 330010316 | 330008582 | 1.8 | 87.6 | Disease modification (D) | 2017-07-17 | 2018-01-08 | VAI (Ifos 3g/m2) | 02 | N | 330013267 | VAI |
| 330010317 | 330004747 | 1.84 | null | Palliative (P) | 2016-01-08 | 2016-01-10 | VAI (Ifos 3g/m2) | N | null | 330013274 | VAI |
| 330010318 | 330004750 | 1.68 | 71.5 | Disease modification (D) | 2016-04-09 | 2016-04-09 | CARBOPLATIN + PACLITAXEL | N | N | 330013281 | CARBOPLATIN + PACLITAXEL |
| 330010319 | 330004754 | 0 | 65 | Palliative (P) | 2013-05-12 | 2013-05-12 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330013284 | BENDAMUSTINE + RITUXIMAB |
| 330010320 | 330004756 | null | 73 | Curative (C) | null | 2014-09-07 | CETUXIMAB + RT | null | null | 330013286 | CETUXIMAB + RT |
| 330010321 | 330008588 | 1.68 | 62.7 | Neo-adjuvant (N) | 2014-09-10 | 2016-11-21 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 330013303 | CARBO + FLUOROURACIL |
| 330010322 | 330008589 | 1.56 | 90.2 | Palliative (P) | 2014-05-28 | 2014-06-28 | VAI (Ifos 3g/m2) | N | Y | 330013306 | VAI |
| 330010323 | 330008590 | 0 | 76.7 | Curative (C) | 2017-05-11 | 2017-05-11 | ALL UKALL2011 Del Int C Reind PAsp | 02 | N | 330013308 | UKALL2011 |
| 330010324 | 330004764 | null | 62.25 | Palliative (P) | null | 2017-07-16 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 2 | N | 330013311 | UKALL2011 |
| 330010325 | 330004766 | null | null | Curative (C) | 2016-01-05 | 2016-05-06 | Paclitaxel (2 or 3 weekly) | 2 | null | 330013316 | PACLITAXEL |
| 330010326 | 330004768 | 1.6 | null | Curative (C) | 2014-09-24 | 2014-09-25 | CARBOPLATIN + RT | 02 | N | 330013318 | CARBOPLATIN + RT |
| 330010327 | 330004770 | 1.59 | 15.2 | Palliative (P) | 2015-06-04 | 2016-07-10 | Carboplatin + Paclitaxel (3 weekly) | 1 | N | 330013323 | CARBOPLATIN + PACLITAXEL |
| 330010328 | 330008598 | null | null | Disease modification (D) | 2016-10-09 | 2016-11-08 | ALL UKALL2011 Del Int C Recon PAsp | N | null | 330013345 | UKALL2011 |
| 330010330 | 330004777 | null | 14.9 | Curative (C) | 2016-07-15 | 2016-07-17 | EURAMOS TRIAL | N | null | 330013480 | EURAMOS TRIAL |
| 330010331 | 330004778 | 1.7 | 58.9 | Palliative (P) | 2017-03-10 | 2017-03-16 | Carboplatin + Etoposide iv&po | 2 | N | 330013489 | CARBOPLATIN + ETOPOSIDE |
| 330010333 | 330004781 | 1.69 | 14.4 | Palliative (P) | 2014-07-01 | 2014-07-03 | Carboplatin + Etoposide iv&po | 02 | N | 330013513 | CARBOPLATIN + ETOPOSIDE |
| 330010334 | 330004782 | null | 103.2 | Curative (C) | 2016-12-22 | 2017-06-29 | VAI (Ifos 3g/m2) | Y | null | 330013532 | VAI |
| 330010335 | 330004782 | 0 | null | Curative (C) | 2018-04-22 | 2018-06-01 | ALL UKALL 2011 HD MtxB (Protocol M) | N | N | 330013532 | UKALL2011 |
| 330010336 | 330008607 | 1.56 | null | Palliative (P) | 2018-09-10 | 2018-09-24 | Carboplatin + Etoposide IV 3 day | 2 | N | 330013561 | CARBOPLATIN + ETOPOSIDE |
| 330010337 | 330004789 | null | 64 | Palliative (P) | 2014-02-28 | 2014-02-28 | Paclitaxel (2 or 3 weekly) | N | N | 330013618 | PACLITAXEL |
| 330010338 | 330004790 | null | 71 | Palliative (P) | 2016-01-08 | 2016-01-08 | VAI (Ifos 3g/m2) | null | null | 330013620 | VAI |
| 330010339 | 330008609 | null | 49.95 | Curative (C) | 2014-07-19 | 2014-07-19 | VAI (Ifos 3g/m2) | 2 | N | 330013620 | VAI |
| 330010340 | 330004793 | null | 41 | Palliative (P) | 2013-08-18 | 2013-08-20 | Cetuximab + Radiotherapy Maint | N | N | 330013680 | CETUXIMAB + RT |
| 330010341 | 330010666 | 1.73 | 71 | Not known (9) | 2014-09-23 | 2014-09-29 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330013711 | CARBO + FLUOROURACIL |
| 330010343 | 330011814 | null | null | Palliative (P) | 2017-03-21 | 2017-03-20 | CARBOPLATIN + PACLITAXEL | null | null | 330013738 | CARBOPLATIN + PACLITAXEL |
| 330010344 | 330011814 | 1.69 | 85.8 | Curative (C) | 2016-10-03 | 2016-11-18 | VAI (Ifos 3g/m2) | 02 | N | 330013738 | VAI |
| 330010345 | 330004801 | 1.78 | 62.2 | Palliative (P) | 2017-06-13 | 2017-06-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330013757 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010346 | 330004803 | null | null | Palliative (P) | 2018-07-30 | 2018-08-01 | EURAMOS TRIAL | 02 | null | 330013778 | EURAMOS TRIAL |
| 330010347 | 330004806 | 1.69 | null | Palliative (P) | 2017-07-02 | 2017-07-24 | CNS Low Grade Glioma Vinblastine | Y | N | 330013824 | NIVOLUMAB |
| 330010349 | 330004810 | 1.61 | 87.8 | Neo-adjuvant (N) | 2017-12-12 | 2017-12-12 | NIVOLUMAB | N | N | 330013886 | CISPLATIN + ETOPOSIDE |
| 330010350 | 330004811 | 1.66 | 77.1 | Curative (C) | 2016-07-24 | 2016-07-24 | EW EuroEwing 2012 Arm A VIDE | N | N | 330013895 | EURO-EWING |
| 330010351 | 330004812 | null | 112 | Neo-adjuvant (N) | 2017-04-05 | 2017-04-07 | Cytarabine High Dose | N | N | 330013921 | CYTARABINE HIGH DOSE |
| 330010352 | 330004815 | null | 86.4 | Curative (C) | 2017-08-08 | 2017-08-22 | Methotrexate intrathecal | 02 | N | 330013930 | METHOTREXATE INTRATHECAL |
| 330010353 | 330004818 | 1.63 | 66.6 | Palliative (P) | 2016-07-09 | 2016-11-09 | Methotrexate intrathecal | null | null | 330013942 | METHOTREXATE INTRATHECAL |
| 330010354 | 330008631 | 1.69 | 14.9 | Curative (C) | 2015-04-12 | 2015-04-22 | Etoposide oral | null | null | 330013959 | ETOPOSIDE |
| 330010355 | 330004824 | 0 | 66.6 | Curative (C) | 2017-10-23 | 2017-10-25 | CNS Low Grade Glioma Vinblastine | N | null | 330013969 | CISPLATIN + DOXORUBICIN |